DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

44.85 0.30 (0.67%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RDY $44.85 0.67%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.43
Previous Close $44.55
Daily Range $44.68 - $45.60
52-Week Range $40.68 - $68.00
Market Cap $7.7B
P/E Ratio 21.21
Dividend (Yield) $0.31 (0.7%)
Ex-Dividend Date
Dividend Pay Date
07/08/15
08/17/15
Volume 325,123
Average Daily Volume 399,211
Current FY EPS $2.37

Sector

Healthcare

Industry

Drug Makers

Dr. Reddy's Laboratories (RDY) Description

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc. Website: http://www.drreddys.com/

News & Commentary

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be down, but they're far from out.

Mallinckrodt Beats Q1 Earnings on Acthar & Inomax, Ups View

Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules

Dr. Reddy's Receives FDA Tentative Approval for Zenavod Capsules, 40 mg for Treatment of Rosacea in

Dr. Reddy's Receives FDA Tentative Approval for Zenavod Capsules, 40 mg for Treatment of Rosacea in Adults

Dr. Reddy's. Receives FDA Approval for ZEMBRACE SymTouch Injection for Acute Treatment of Migraines

Dr. Reddy's. Receives FDA Approval for ZEMBRACE SymTouch Injection for Acute Treatment of Migraines in Adults

India Is The New China: Investing In India's Demographic Dividend

Ken Fisher Sells Shares of PMC Sierra, Alphabet During 4th Quarter

Asian ADRs Down Slightly as eCommerce Stocks See Mixed Fortunes

Dr. Reddy's (RDY) Relaunches Generic Nexium in the U.S.

Asian ADRs Advance as China Finance Online Shares Surge 38 Per Cent

See More RDY News...

RDY's Top Competitors

RDY $44.85 (0.67%)
Current stock: RDY
JNJ $100.54 (-3.23%)
Current stock: JNJ
NVS $74.33 (-0.97%)
Current stock: NVS
RHHBY $31.69 (-1.18%)
Current stock: RHHBY